Active, not recruiting
Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer
|2||Active, not recruiting||
Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer
Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
† Study has passed its completion date and status has not been verified in more than two years.